| Mepha Pharma AG - Levetiracetam-Mepha 500 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 62615 | | 01 | | Levetiracetam-Mepha 500 mg/5 ml | | Konzentrat zur Herstellung einer Infusionslösung | | N03AX14 | | Levetiracetam | | 08.04.2013 | | |
|
| Composition |
| levetiracetamum 500 mg, natrii acetas trihydricus, natrii chloridum corresp. natrium 19.1 mg, aqua ad iniectabile q.s. ad solutionem pro 5 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | Active Agent | Dose |
|---|
| Levetiracetame | 500mg / 5ml |
| | | | Inactive agents |
|---|
| Sodium Acetate Trihydrate | | Sodium Chloride |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Durchstechflasche(n) | PR | PR | B | | Yes | | 002 | 10 Durchstechflasche(n) | PR | PR | B | | Yes |
|
